Published on 16 Dec 2023 on GuruFocus.com via Yahoo Finance
Insider Sell Alert: SVP, Chief Technical Officer Michael Labarre Sells 20,000 Shares of ...
Halozyme Therapeutics Inc (NASDAQ:HALO), a biopharmaceutical company known for its novel enzyme technology that targets the extracellular matrix, has recently witnessed a significant insider sell transaction. Michael Labarre, the company's Senior Vice President and Chief Technical Officer, sold 20,000 shares of the company's stock on December 13, 2023. This move has caught the attention of investors and market analysts, prompting a closer look at the insider's trading behavior and the potential implications for the stock's valuation and future performance.
Who is Michael Labarre of Halozyme Therapeutics Inc?
Warning! GuruFocus has detected 3 Warning Signs with HALO.